Journal of Cardiovascular Disease Research
MANUSCRIPT TITLE: AN UPDATE ON CURRENT USAGE OF SGLT2-INHIBITORS IN HEART FAILURE WITH REDUCED EJECTION FRACTION: SPECIAL FOCUS ON DAPAGLIFLOZIN
Dr. Jay Shah, MD, DNB (Cardiology) FACC, FESC, 2Dr Johann Christopher MD DNB FACC , 3Dr. Saketkant, MD, DM, 4Dr. Soumik Goswami, MD, DM (Endocrinology), 5Dr. Biswajit Aich, 6Dr.Sameer K. Muchhala.
JCDR. 2021: 2454-2463
» PDF